´ëÇѽÅÀåÇÐȸ Á¦14ȸ Nephrology Board Review Course 2020 : 2020-02-16±³À°ÀÏÀÚ : 2020-02-16
±³À°Àå¼Ò : ¼¿ï, ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ
±³À°ÁÖÁ¦ :
Á¦14ȸ Nephrology Board Review Course 2020ÁÖÃÖ±â°ü : ´ëÇѽÅÀåÇÐȸ
´ã´çÀÚ : »ç¹«±¹
¿¬¶ôó : 02-3486-8736
À̸ÞÀÏ :
ksn@ksn.or.kr ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 400¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 6 ½Ã°£ 30ºÐ
¼¼ºÎ¼ö°·á : 160,000¿ø
ºñ°í 1Àϵî·Ï: 80,000¿ø 2Àϵî·Ï: 160,000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 02-16 ÄÁº¥¼ÇȦ 09:30~10:00 Anemia in CKD: How does it treat? What ±è¼º±Õ(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 02-16 ÄÁº¥¼ÇȦ 10:00~10:30 Management of hypertension in CKD: beyond the guidelines ·ùµ¿¿(ÀÌÈÀÇ´ë)
±³À°½Ã°£ 02-16 ÄÁº¥¼ÇȦ 10:30~11:00 Diabetic kidney disease: current best practice ¹ÚöÈÖ(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 02-16 ÄÁº¥¼ÇȦ 11:00~11:30 Osteoporosis, bone mineral density and CKD-MBD: update °í°Áö(°í·ÁÀÇ´ë)
±³À°½Ã°£ 02-16 ÄÁº¥¼ÇȦ 12:30~13:00 Metabolic evaluation and management of stone disease À±¼¼Èñ(°Ç¾çÀÇ´ë)
±³À°½Ã°£ 02-16 ÄÁº¥¼ÇȦ 13:00~13:30 Update and review of adult polycystic kidney disease À̱Թé(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 02-16 ÄÁº¥¼ÇȦ 13:30~14:00 Kidney disease and pregnancy: practice essentials ÀÌÁ¤Ç¥(¼¿ïÀÇ´ë)
±³À°½Ã°£ 02-16 ÄÁº¥¼ÇȦ 14:10~14:40 Making PD prescription: from evidence to practice ¿À±¹È¯(¼¿ïÀÇ´ë)
±³À°½Ã°£ 02-16 ÄÁº¥¼ÇȦ 14:40~15:10 Treatment of infectious and non-infectious complications in PD ¹Ú¼±Èñ(°æºÏÀÇ´ë)
±³À°½Ã°£ 02-16 ÄÁº¥¼ÇȦ 15:10~15:40 Strategies to improve CV outcomes in dialysis patients °¼®ÈÖ(¿µ³²ÀÇ´ë)
±³À°½Ã°£ 02-16 ÄÁº¥¼ÇȦ 15:50~16:20 Making HD prescription: from evidence to practice °°æÇ¥(ÀüºÏÀÇ´ë)
±³À°½Ã°£ 02-16 ÄÁº¥¼ÇȦ 16:20~16:50 Prevention and treatment of dialysis catheter malfunction & infections ȲÇö¼®(°æÈñÀÇ´ë)
±³À°½Ã°£ 02-16 ÄÁº¥¼ÇȦ 16:50~17:20 Spectrum of intradialytic complications during hemodialysis & its management °¼±¿ì(ÀÎÁ¦ÀÇ´ë)